Bronchioloalveolar carcinoma and lung adenocarcinoma: The clinical importance and research relevance of the 2004 world health organization pathologic criteria

Journal of Thoracic Oncology

Volumn 1, Issue 9 SUPPL., 2006, Pages

  Travis, William D ^a   Garg, Kavita ^b   Franklin, Wilbur A ^b   Wistuba, Ignacio I ^c   Sabloff, Bradley ^c   Noguchi, Masayuki ^d   Kakinuma, Ryutaro ^e   Zakowski, Maureen ^a   Ginsberg, Michelle ^a   Padera, Robert ^f   Jacobson, Francine ^f   Johnson, Bruce E ^g   Hirsch, Fred ^b   Brambilla, Elizabeth ^h   Flieder, Douglas B ⁱ   Geisinger, Kim R ^j   Thunnissen, Frederik ^k   Kerr, Keith ^l   Yankelevitz, David ^m   Franks, Teri J ⁿ   Galvin, Jeffrey R ^o   Henderson, Douglas W ^p   Nicholson, Andrew G ^q   Hasleton, Philip S ^r   Roggli, Victor ^s   Tsao, Ming Sound ^t   Cappuzzo, Federico ^u   Vazquez, Madeline ^m   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e NATIONAL CANCER CENTER   (Japan)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h GRENOBLE UNIVERSITY HOSPITAL   (France)

ⁱ FOX CHASE CANCER CENTER   (United States)

^j WAKE FOREST SCHOOL OF MEDICINE   (United States)

^k CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^l UNIVERSITY OF ABERDEEN   (United Kingdom)

^m NEW YORK PRESBYTERIAN HOSPITAL   (United States)

ⁿ ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^o UNIVERSITY OF MARYLAND   (United States)

^p FLINDERS MEDICAL CENTRE   (Australia)

^q ROYAL BROMPTON HOSPITAL   (United Kingdom)

^r UNIVERSITY OF MANCHESTER   (United Kingdom)

^s DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t PRINCESS MARGARET HOSPITAL   (Canada)

^u BELLARIA HOSPITAL   (Italy)

more..

Author keywords

Adenocarcinoma; Bronchioloalveolar carcinoma; Classification; Lung cancer; Pathology; Radiology

Indexed keywords

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; HEALTH SURVEY; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG NODULE; MEDICAL RESEARCH; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; RADIOLOGY; SURVIVAL RATE; SURVIVAL TIME; TUMOR BIOPSY; WORLD HEALTH ORGANIZATION; ADENOCARCINOMA; CLASSIFICATION; CONSENSUS DEVELOPMENT; CYTODIAGNOSIS; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MALE; METHODOLOGY; NEEDLE BIOPSY; RADIOGRAPHY; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; BIOPSY, NEEDLE; CYTODIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WORLD HEALTH ORGANIZATION;

EID: 34247890114     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/s1556-0864(15)30004-6     Document Type: Conference Paper

References (43)

1. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005;23:3279-3287.
2. Janne PA, Gurubhagavatula S, Yeap BY, et al. Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study. Lung Cancer 2004;44:221-230.
3. Miller VA, Kris MG, Shah N, et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol 2004;22:1103-1109.
4. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-1500.
5. Kaneko M, Kusumoto M, Kobayashi T, et al. Computed tomography screening for lung carcinoma in Japan. Cancer 2000;89:2485-2488.
6. Sone S, Li F, Yang ZG, et al. Characteristics of small lung cancers invisible on conventional chest radiography and detected by population based screening using spiral CT. Br J Radiol 2000;73:137-145.
7. Suzuki K, Yokose T, Yoshida J, et al. Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. Ann Thorac Surg 2000;69:893-897.
8. Swensen SJ, Jett JR, Hartman TE, et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003;226:756-761.
9. Yokose T, Suzuki K, Nagai K, Nishiwaki Y, Sasaki S, Ochiai A. Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Lung Cancer 2000;29:179-188.
10. Pao W, Wang TY, Riely GJ, et al. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLoS Med 2005;2:e17.
11. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64:8919-8923.
12. Pao W, Miller V, Zakowski M, et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A 2004;101:13306-13311.
13. Goldstein NS, Mani A, Chmielewski G, Welsh R, Pursel S. Prognostic factors in T1 NO MO adenocarcinomas and bronchioloalveolar carcinomas of the lung. Am J Clin Pathol 1999;112:391-402.
14. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995;75:2844-2852.
15. Sakurai H, Dobashi Y, Mizutani E, et al. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment. Ann Thorac Surg 2004;78:1728-1733.
16. Terasaki H, Niki T, Matsuno Y, et al. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol 2003;27:937-951.
17. Furak J, Trojan I, Szoke T, et al. Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival. Eur J Cardiothorac Surg 2003;23:818-823.
18. Miller VA, Hirsch FR, Johnson DH. Systemic therapy of advanced bronchioloalveolar cell carcinoma: challenges and opportunities. J Clin Oncol 2005;23:3288-3293.
19. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, in collaboration with L. H. Sobin and pathologists from 14 countries. Histological Typing of Lung and Pleural Tumors, 3rd ed. Berlin: Springer, 1999.
20. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC, 2004.
21. World Health Organization. Histological Typing of Lung Tumors, 2 ed. Geneva: World Health Organization, 1981.
22. Zell JA, Ou SH, Ziogas A, Anton-Culver H. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol 2005;23:8396-8405.
23. Takashima S, Maruyama Y, Hasegawa M, Saito A, Haniuda M, Kadoya M. High-resolution ct features: prognostic significance in peripheral lung adenocarcinoma with bronchioloalveolar carcinoma components. Respiration 2003;70:36-42.
24. Mirtcheva RM, Vazquez M, Yankelevitz DF, Henschke CI. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT. Clin Imaging 2002;26:95-100.
25. Takashima S, Li F, Maruyama Y, et al. Discrimination of subtypes of small adenocarcinoma in the lung with thin-section CT. Lung Cancer 2002;36:175-182.
26. Kodama K, Higashiyama M, Yokouchi H, et al. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 2001;33:17-25.
27. Clayton F. Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates. Cancer 1986;57:1555-1564.
28. Colby TV, Koss MN, Travis WD. Tumors of the Lower Respiratory Tract; Armed Forces Institute of Pathology Fascicle, Third Series. Washington, DC: Armed Forces Institute of Pathology, 1995.
29. Thompson WH. Bronchioloalveolar carcinoma masquerading as pneumonia. Respir Care 2004;49:1349-1353.
30. Akira M, Atagi S, Kawahara M, Iuchi K, Johkoh T. High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients. AJR Am J Roentgenol 1999;173:1623-1629.
31. Ohori NP, Santa Maria, EL. Cytopathologic diagnosis of bronchioloalveolar carcinoma: does it correlate with the 1999 World Health Organization definition? Am J Clin Pathol 2004;122:44-50.
32. Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol 2004;28:198-206.
33. Takashima S, Maruyama Y, Hasegawa M, et al. Prognostic significance of high-resolution CT findings in small peripheral adenocarcinoma of the lung: a retrospective study on 64 patients. Lung Cancer 2002;36:289-295.
34. Aoki T, Tomoda Y, Watanabe H, et al. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001;220:803-809.
35. Yang ZG, Sone S, Takashima S, et al. High-resolution CT analysis of small peripheral lung adenocarcinomas revealed on screening helical CT. AJR Am J Roentgenol 2001;176:1399-1407.
36. Nakamura H, Saji H, Ogata A, Saijo T, Okada S, Kato H. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer 2004;44:61-68.
37. Battafarano RJ, Meyers BF, Guthrie TJ, Cooper JD, Patterson GA. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival. Ann Thorac Surg 2002;74:988-993.
38. Daly RC, Trastek VF, Pairolero PC, et al. Bronchoalveolar carcinoma: factors affecting survival. Ann Thorac Surg 1991;51:368-376.
39. McElvaney G, Miller RR, Muller NL, Nelems B, Evans KG, Ostrow DN. Multicentricity of adenocarcinoma of the lung. Chest 1989;95:151-154.
40. Nadav Y, Pastorino U, Nicholson AG. Multiple synchronous lung cancers and atypical adenomatous hyperplasia in Li-Fraumeni syndrome. Histopathology 1998;33:52-54.
41. Rusch VW, Appelman HD, Byhardt R, et al. Lung. In FL Greene, DL Page, ID Fleming, et al., eds. AJCC Cancer Staging Manual, 6th ed. New York: Springer-Verlag, 2002, pp 167-181.
42. Roberts PF, Straznicka M, Lara PN, et al. Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved. J Thorac Cardiovasc Surg 2003;126:1597-1602.
43. World Health Organization. Histological Typing of Lung Tumours, 1st ed. Geneva: World Health Organization, 1967.